About VIB (101)
Bio imaging core (1)
Business opportunities (14)
Cardiovascular medicine (21)
Cell biology (11)
Developmental biology (4)
Inflammation and immunity (42)
International PhD Program (1)
Plant biology (87)
Research Areas (2)
Structural biology (20)
Systems biology (7)
Page Content Zone 1
Peter Carmeliet patron of the Andreas Vesalius exhibition in Leuven
1 October 2014
Peter Carmeliet was asked to be the patron of the Vesalius exhibition ‘Vesalius gets under your skin’ at the M-Museum in Leuven, where he will hold a lecture for a broad audience on Tuesday, November 18.
New genes identified with key role in the development of severe childhood epilepsies
25 September 2014
An international team of researchers, including scientists from VIB and Antwerp University identified novel causes for severe childhood epilepsies.
A look at new breeding technologies from a regulatory viewpoint
24 September 2014
There are now new breeding technologies (NBTs) out there and, under European GMO legislation, it is far from clear what classification should be applied to the plants they produce.
Plant Organ Growth Symposium
23 September 2014
You are invited to the ‘Plant Organ Growth Symposium’ that will take place in Ghent (Belgium) from 10-12 March, 2015 . The aim of the meeting is to discuss state of the art knowledge on the mechanisms that govern plant organ growth and size control
Inflammasome research provides insight into rheumatoid arthritis
22 September 2014
Lieselotte Vande Walle and Mo Lamkanfi (VIB Department of Medical Protein Research, UGent) demonstrated with their inflammasome research that rheumatoid arthritis should be considered a syndrome rather than a disease.
Interview with Bart Lambrecht
18 September 2014
Immunology is one of the major research themes at VIB. And we will be focusing on this theme in the fall. In December, VIB and Cell will join forces to organize the international conference “The multifaceted roles of type 2 immunity”.
Let's share our fascination for science!
16 September 2014
From science to value for society – that is the VIB motto. The ingredients, required for this, are obvious to most of us: strategic basic research linked to an active valorization policy.
New insights in survival strategies of bacteria
14 September 2014
Scientists at VIB /VUB have created a detailed 3-D image of the pores in bacteria through which curli building blocks cross the bacterial cell wall, a crucial step in the formation of the protective slime capsule.
Jeffrey Modell Foundation supports Belgian research on primary immunodeficiency
9 September 2014
For the first time the Jeffrey Modell Foundation is giving a research grant to a Belgian laboratory. The team of Adrian Liston from VIB-KU Leuven will use the grant to develop a gene therapy to cure children that suffer from IPEX syndrome.
Keeping the gut barrier intact - The thin line between cell survival and cell death
3 September 2014
Under normal conditions, RIPK1 is essential to protect gut epithelial cells from excessive cell death, and thereby ensures the barrier function of this organ from bacterial infiltration.
Nature Biotechnology article describes new Dutch technology that improves DNA sequencing
27 August 2014
Cergentis, in collaboration with the Hubrecht Institute, has developed a new technology for DNA sequencing. The new technology and various applications are described in an article appearing this week in the journal Nature Biotechnology.
ALS Ice Bucket challenge - VIB HQ
27 August 2014
With pleasure we joined this initiative to raise awareness for ALS diseases and to raise funds in the fight against ALS.
The Ghent University and the Flemish Institute for Biotechnology conclude a strategic alliance with Eiland Zwijnaarde plc
21 August 2014
Ghent University and VIB will co-operate in the development of a new industrial site for R&D companies on Eiland Zwijnaarde, fostering the establishment of R&D intensive companies and enabling 2.000 jobs in the Ghent Region.
Zebrafish help to unravel Alzheimer’s disease
19 August 2014
A new by VIB/KU Leuven scientists gives new knowledge about the regulation of stem cells in the nerve tissue of zebrafish embryos results in surprising insights into neurodegenerative disease processes in the human brain.
Malaria medicine chloroquine inhibits tumor growth and metastases
11 August 2014
A study by investigators at VIB and KU Leuven has demonstrated that chloroquine also normalizes the abnormal blood vessels in tumors. This blood vessel normalization results in an increased barrier function and in enhanced tumor perfusion.
Page Content Zone 2
Page Content Zone 3
Get news updates:
Follow us on Twitter
Like us on Facebook
Inflammation and immunity
Training and facilities
Int. Ph.D. Program